Informationen: Dieses ist nicht die aktuellste Version des Datenmodells. Eine Versionsübersicht finden Sie links unter Versionen. Die aktuellste Version finden Sie hier.
Informationen:
Fehler:
ID
20674
Beschreibung
Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00380445
Link
https://clinicaltrials.gov/show/NCT00380445
Stichworte
Versionen (2)
- 10.03.17 10.03.17 -
- 17.09.21 17.09.21 -
Hochgeladen am
10. März 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes Mellitus, Type 2 NCT00380445
Eligibility Diabetes Mellitus, Type 2 NCT00380445
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes Mellitus, Type 2 NCT00380445
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Antidiabetics | Washout Period Completion Able
Item
must be able to complete a 3-week wash-out of current anti-diabetic medication
boolean
C0935929 (UMLS CUI [1])
C1710661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
C1710661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
Pharmaceutical Preparations Resulting in Altered gastric motility | Cardiac agent Dose Stable
Item
cannot take any medications which may alter gastric motility except for cardiac medication at a stable dose
boolean
C0013227 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0548822 (UMLS CUI [1,3])
C0280076 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0332294 (UMLS CUI [1,2])
C0548822 (UMLS CUI [1,3])
C0280076 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Adrenergic beta-1 Receptor Antagonists To be stopped | Antilipemic agent To be stopped
Item
must discontinue beta-blockers and lipid lowering drugs
boolean
C0304516 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C0003367 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C1272691 (UMLS CUI [1,2])
C0003367 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Blood Glucose criteria Fulfill
Item
blood glucose criteria must be met
boolean
C0005802 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Body mass index
Item
bmi in the range 30-35
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus
Item
history of type 1 diabetes, diabetes resulting from pancreatic injury, or secondary forms of diabetes
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
Insulin Patient need for | Thiazolidinediones
Item
need for insulin within 3 months or patients on thiazolidinediones
boolean
C0021641 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2])
C0686904 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2])
Sulfonylurea | Metformin | Pharmaceutical Preparations Discontinue Unable
Item
patients taking a sulfonylurea or metformin who cannot safely discontinue medication for the duration of the study
boolean
C0038766 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
C0025598 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Comorbidity | Complications of Diabetes Mellitus
Item
significant concomitant disease or complications of diabetes
boolean
C0009488 (UMLS CUI [1])
C0342257 (UMLS CUI [2])
C0342257 (UMLS CUI [2])
Gastrointestinal Surgical Procedure | Gastrointestinal symptom Positive
Item
patients with any history of gastrointestinal surgery or positive gastrointestinal symptons
boolean
C0524722 (UMLS CUI [1])
C0426576 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0426576 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Triglycerides High
Item
high tryglycerides as defined by the protocol
boolean
C0041004 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,2])
Tobacco use Abstinence Unable
Item
smokers who cannot abstain from smoking during the treatment periods
boolean
C0543414 (UMLS CUI [1,1])
C3843422 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C3843422 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])